Literature DB >> 12823474

Anterograde delivery of brain-derived neurotrophic factor to striatum via nigral transduction of recombinant adeno-associated virus increases neuronal death but promotes neurogenic response following stroke.

Elin Gustafsson1, Gunnar Andsberg, Vladimer Darsalia, Paul Mohapel, Ronald J Mandel, Deniz Kirik, Olle Lindvall, Zaal Kokaia.   

Abstract

To explore the role of brain-derived neurotrophic factor for survival and generation of striatal neurons after stroke, recombinant adeno-associated viral vectors carrying brain-derived neurotrophic factor or green fluorescent protein genes were injected into right rat substantia nigra 4-5 weeks prior to 30 min ipsilateral of middle cerebral artery occlusion. The brain-derived neurotrophic factor-recombinant adeno-associated viral transduction markedly increased the production of brain-derived neurotrophic factor protein by nigral cells. Brain-derived neurotrophic factor was transported anterogradely to the striatum and released in biologically active form, as revealed by the hypertrophic response of striatal neuropeptide Y-positive interneurons. Animals transduced with brain-derived neurotrophic factor-recombinant adeno-associated virus also exhibited abnormalities in body posture and movements, including tilted body to the right, choreiform movements of left forelimb and head, and spontaneous, so-called 'barrel' rotation along their long axis. The continuous delivery of brain-derived neurotrophic factor had no effect on the survival of striatal projection neurons after stroke, but exaggerated the loss of cholinergic, and parvalbumin- and neuropeptide Y-positive, gamma-aminobutyric acid-ergic interneurons. The high brain-derived neurotrophic factor levels in the animals subjected to stroke also gave rise to an increased number of striatal cells expressing doublecortin, a marker for migrating neuroblasts, and cells double-labelled with the mitotic marker, 5-bromo-2'-deoxyuridine-5'monophosphate, and early neuronal (Hu) or striatal neuronal (Meis2) markers. Our findings indicate that long-term anterograde delivery of high levels of brain-derived neurotrophic factor increases the vulnerability of striatal interneurons to stroke-induced damage. Concomitantly, brain-derived neurotrophic factor potentiates the stroke-induced neurogenic response, at least at early stages.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12823474     DOI: 10.1046/j.1460-9568.2003.02713.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  14 in total

Review 1.  Anterograde transport of neurotrophic factors: possible therapeutic implications.

Authors:  Matteo Caleo; Maria Cristina Cenni
Journal:  Mol Neurobiol       Date:  2004-04       Impact factor: 5.590

2.  Genetic variant of BDNF (Val66Met) polymorphism attenuates stroke-induced angiogenic responses by enhancing anti-angiogenic mediator CD36 expression.

Authors:  Luye Qin; Eunhee Kim; Rajiv Ratan; Francis S Lee; Sunghee Cho
Journal:  J Neurosci       Date:  2011-01-12       Impact factor: 6.167

Review 3.  Progress in the identification of stroke-related genes: emerging new possibilities to develop concepts in stroke therapy.

Authors:  Andrea Lippoldt; Andreas Reichel; Ursula Moenning
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration.

Authors:  R L Nosheny; I Mocchetti; A Bachis
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

Review 5.  Neurogenesis following Stroke Affecting the Adult Brain.

Authors:  Olle Lindvall; Zaal Kokaia
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-11-02       Impact factor: 10.005

Review 6.  Drug delivery systems for the treatment of ischemic stroke.

Authors:  Taiyoun Rhim; Dong Yun Lee; Minhyung Lee
Journal:  Pharm Res       Date:  2013-01-10       Impact factor: 4.200

Review 7.  CD36 as a therapeutic target for endothelial dysfunction in stroke.

Authors:  Sunghee Cho
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 8.  Gene delivery with viral vectors for cerebrovascular diseases.

Authors:  Yu Gan; Zheng Jing; Ruth Anne Stetler; Guodong Cao
Journal:  Front Biosci (Elite Ed)       Date:  2013-01-01

9.  Strategies for regenerating striatal neurons in the adult brain by using endogenous neural stem cells.

Authors:  Kanako Nakaguchi; Hiroshi Masuda; Naoko Kaneko; Kazunobu Sawamoto
Journal:  Neurol Res Int       Date:  2011-06-02

10.  Is Melanoma a stem cell tumor? Identification of neurogenic proteins in trans-differentiated cells.

Authors:  Suraiya Rasheed; Zisu Mao; Jane Mc Chan; Linda S Chan
Journal:  J Transl Med       Date:  2005-03-22       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.